Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 1
1969 1
1971 1
1972 1
1973 2
1974 4
1978 2
1979 3
1980 3
1981 4
1983 1
1987 2
1988 1
1989 2
1991 2
1992 1
1993 1
1994 3
1995 2
1996 4
1997 1
1998 4
1999 1
2000 3
2001 2
2002 2
2003 8
2004 5
2005 7
2006 8
2007 5
2008 4
2009 5
2010 5
2011 3
2012 7
2013 10
2014 17
2015 13
2016 14
2017 13
2018 11
2019 17
2020 21
2021 31
2022 20
2023 24
2024 26
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr; INSPIRE and COMMAND Study Group. Louis E, et al. JAMA. 2024 Sep 17;332(11):881-897. doi: 10.1001/jama.2024.12414. JAMA. 2024. PMID: 39037800 Clinical Trial.
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets.
Ohta A, Tanada M, Shinohara S, Morita Y, Nakano K, Yamagishi Y, Takano R, Kariyuki S, Iida T, Matsuo A, Ozeki K, Emura T, Sakurai Y, Takano K, Higashida A, Kojima M, Muraoka T, Takeyama R, Kato T, Kimura K, Ogawa K, Ohara K, Tanaka S, Kikuchi Y, Hisada N, Hayashi R, Nishimura Y, Nomura K, Tachibana T, Irie M, Kawada H, Torizawa T, Murao N, Kotake T, Tanaka M, Ishikawa S, Miyake T, Tamiya M, Arai M, Chiyoda A, Akai S, Sase H, Kuramoto S, Ito T, Shiraishi T, Kojima T, Iikura H. Ohta A, et al. Among authors: ozeki k. J Am Chem Soc. 2023 Nov 8;145(44):24035-24051. doi: 10.1021/jacs.3c07145. Epub 2023 Oct 24. J Am Chem Soc. 2023. PMID: 37874670
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Aliment Pharmacol Ther. 2024 Jul;60(1):43-51. doi: 10.1111/apt.18013. Epub 2024 Apr 23. Aliment Pharmacol Ther. 2024. PMID: 38651779
Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study.
Kurosawa S, Shimomura Y, Ishiyama K, Fuse K, Shimazu Y, Doki N, Uchida N, Tanaka M, Takahashi S, Sakurai M, Kobayashi H, Katayama Y, Takada S, Ozeki K, Nakamae H, Ishimaru F, Kanda Y, Ichinohe T, Atsuta Y, Itonaga H. Kurosawa S, et al. Among authors: ozeki k. Bone Marrow Transplant. 2024 Jun;59(6):742-750. doi: 10.1038/s41409-024-02223-4. Epub 2024 Feb 8. Bone Marrow Transplant. 2024. PMID: 38331981
Single-conflict colouring.
Dvořák Z, Esperet L, Kang RJ, Ozeki K. Dvořák Z, et al. Among authors: ozeki k. J Graph Theory. 2021 May;97(1):148-160. doi: 10.1002/jgt.22646. Epub 2020 Nov 4. J Graph Theory. 2021. PMID: 33888935 Free PMC article.
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.
Yokota H, Miyao K, Sawa M, Terakura S, Kurahashi S, Ikoma Y, Imahashi N, Morishita T, Okamoto A, Kajiguchi T, Ono T, Narita T, Kanemura N, Ozeki K, Kojima Y, Naito K, Uchino K, Tomita A, Iida H, Imoto N, Kasahara S, Inagaki Y, Nishida T, Murata M. Yokota H, et al. Among authors: ozeki k. J Hematol. 2024 Aug;13(4):142-149. doi: 10.14740/jh1289. Epub 2024 Aug 10. J Hematol. 2024. PMID: 39247063 Free PMC article.
Managing refractory Crohn's disease: challenges and solutions.
Tanida S, Ozeki K, Mizoshita T, Tsukamoto H, Katano T, Kataoka H, Kamiya T, Joh T. Tanida S, et al. Among authors: ozeki k. Clin Exp Gastroenterol. 2015 Apr 10;8:131-40. doi: 10.2147/CEG.S61868. eCollection 2015. Clin Exp Gastroenterol. 2015. PMID: 25914555 Free PMC article. Review.
Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule study.
Omori T, Ohmiya N, Watanabe K, Hirai F, Nakamura M, Kitamura K, Ozeki K, Oka S, Kawano S, Handa O, Kawai M, Ninomiya K, Sagawa T, Wakamatsu T, Araki A, Koike Y, Kato S, Hashimoto S, Mannami T, Nakaji K, Tanaka S, Matsui T; J-POP study group. Omori T, et al. Among authors: ozeki k. J Gastroenterol Hepatol. 2024 Feb;39(2):337-345. doi: 10.1111/jgh.16365. Epub 2023 Oct 16. J Gastroenterol Hepatol. 2024. PMID: 37842961
Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.
Imahashi N, Kurita N, Konuma T, Takahashi S, Nishida T, Tanaka M, Nakamae H, Kawakita T, Ota S, Doki N, Onishi Y, Sawa M, Ozeki K, Hiramoto N, Onizuka M, Ishimaru F, Ichinohe T, Atsuta Y, Kanda J. Imahashi N, et al. Among authors: ozeki k. Transplant Cell Ther. 2024 Mar;30(3):318.e1-318.e11. doi: 10.1016/j.jtct.2023.12.004. Epub 2023 Dec 9. Transplant Cell Ther. 2024. PMID: 38081416
290 results